Adenylate cyclase activation by VIP and PACAP in the retina and choroid: effects of antagonists.
Nilsson
S F
SF
Department of Physiology and Medical Biophysics, University of Uppsala, Sweden. siv.nilsson@fysiologi.uu.se
Amér
M
M
Vandermeers
A
A
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002829:Choroid / Q000201:enzymology*; D004789:Enzyme Activation; D007700:Kinetics; D008252:Macaca fascicularis; D009479:Neuropeptides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011817:Rabbits; D012160:Retina / Q000201:enzymology*; D014660:Vasoactive Intestinal Peptide / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D009479:Neuropeptides; D018377:Neurotransmitter Agents; D010446:Peptide Fragments; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014660:Vasoactive Intestinal Peptide; D000262:Adenylyl Cyclases